Asiaticoside
One of the four key active ingredients of Centella asiatica — asiaticoside stimulates collagen synthesis through a unique mechanism of activating the antimicrobial peptide LL-37, accelerates wound healing, and enhances the effect of madecassoside in skin recovery.
What is it?
Asiaticoside — a triterpenoid saponin isolated from Centella asiatica. One of the four main actives of Centella along with madecassoside, asiatic acid, and madecassic acid. Unlike madecassoside (which inhibits inflammation via NF-κB), asiaticoside acts primarily through the stimulation of the antimicrobial peptide LL-37 synthesis in keratinocytes. LL-37 is a catalyst for collagen synthesis via a TGF-β1-independent pathway. Additionally: asiaticoside is hydrolyzed in the skin to asiatic acid, which directly activates fibroblast proliferation. Clinically used in the Madecassol preparation for the treatment of wounds, burns, and scars — often in combination with madecassoside.
Products for recovery after procedures, scar treatment, soothing reactive skin. Synergistically used together with madecassoside, panthenol, and ceramides. Concentration 0.1–1% in combination with other actives of Centella. Predominantly found in standardized CICA formulas.
Key Benefits
Suitable for
Main Actions
Most modern CICA products contain a combination of several Centella actives: madecassoside + asiaticoside + asiatic acid + madecassic acid. Together they provide a synergistic effect through various mechanisms (NF-κB, TGF-β1, LL-37, EGF). The standardized extract TECA (Titrated Extract of Centella Asiatica) contains 40% asiaticoside, 29–30% asiatic acid, 29–30% madecassic acid, and 1% madecassoside — the gold standard of clinical research.
Check if this ingredient works for your skin — analyze your full product formula for free.
Analyze your product